• About us
    About us
    • Who We Are
    • Background
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
    • Grants
  • Strategy
    Strategy
    • From Vision to Reality
    • Growth Model
  • Governance
    Governance
    • Articles of Association
    • Auditor
    • General Meetings
  • IndiTreat®
    IndiTreat®
    • Clinical Evidence
    • IndiTreat® Downloads
    • IndiTreat® Technology
    • IndiTreat® Tests
  • Investors
    Investors
    • Financial Calendar
    • Reports
    • Reports (in Swedish)
    • Presentations
    • Share Information
    • Ownership Structure
    • Share Issues
    • Analyst Coverage
    • IR Contact 2cureX
  • Newsroom
    Newsroom
    • Press Releases & News
    • 2cureX Blog
    • Newsletter
    • Media Contact
  • Events
    Events
    • 2cureX Events
  • Downloads
  • Contact

2cureX Newsletter

May 1 | 2019
2cureX Newsletter 2nd edition May 1st 2019

https://www.2curex.com/2curex-newsletter-2nd-edition-2019/

Previous Next

About 2cureX

2cureX is pioneering the use of functional drug sensitivity testing to improve the outcome of cancer treatments

Address

2cureX, Fruebjergvej 3,
2100 Copenhagen, Denmark
E-mail info@2cureX.com

Menu

  • About us
  • Strategy
  • Governance
  • IndiTreat®
  • Investors
  • Newsroom
  • Events

Links

  • Privacy Cookies Policy
  • Impressum / Imprint

Follow us

© 2024 2cureX - All rights reserved.
Website design: Deep Identity